Cell-Based Therapy for Neural Disorders — Anticipating Challenges

被引:0
|
作者
Arlene Y. Chiu
Mahendra S. Rao
机构
[1] Beckman Research Institute of the City of Hope,
[2] Life Technologies Corporation,undefined
来源
Neurotherapeutics | 2011年 / 8卷
关键词
Pluripotent stem cells; ESC; CNS roadblocks;
D O I
暂无
中图分类号
学科分类号
摘要
Neurological syndromes, such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, Huntington’s disease, amyotrophic lateral sclerosis, and lysosomal storage disorders, such as Battens disease, are devastating because they result in increasing loss of cognitive and physical function. Sadly, no drugs are currently available to halt their progression. The relative paucity of curative approaches for these and other conditions of the nervous system have led to a widespread evaluation of alternative treatment modalities including cell-based interventions. Several cell types have been tested successfully in animal models where safety and efficacy have been demonstrated. Early clinical trials have also been initiated in humans, and some have shown a degree of success albeit on a more limited scale than in animal experiments. Recent demonstrations that pluripotent stem cells, such as embryonic stem cells and induced pluripotent stem cells, can differentiate into a variety of specific neural phenotypes has stimulated worldwide enthusiasm for developing cell-based intervention of neurological disease. Indeed, several groups are preparing investigational new drug applications to treat disorders as diverse as macular degeneration, lysosomal storage diseases, and Parkinson’s disease. It is noteworthy that cell replacement therapies for neurological conditions face key challenges, some of which are unique, because of the development and organization of the nervous system, its metabolism, and connectivity. Choice of the cell (or cells), the process of manufacturing them, defining the delivery pathway, developing and testing in an appropriate preclinical model, selecting a patient population, and visualizing and following or monitoring patients all pose specific issues as related to the central and peripheral nervous systems. In this review, we address a myriad of challenges that are solvable, but require careful planning and attention to the special demands of the human nervous system.
引用
收藏
页码:744 / 752
页数:8
相关论文
共 50 条
  • [21] Biomimetic material systems for neural progenitor cell-based therapy
    Potter, Wyatt
    Kalil, Ronald E.
    Kao, Weiyuan J.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 806 - 821
  • [22] Neural precursor/stem cell-based therapy for Rett syndrome
    Frasca, A.
    Miramondi, F.
    Butti, E.
    Indrigo, M.
    Balbontin, M.
    Borello, U.
    Bedogni, F.
    Martino, G.
    Landsberger, N.
    GLIA, 2023, 71 : E800 - E801
  • [23] A Neural Stem Cell-Based Therapy for Parkinson's Disease
    Gonzalez, R.
    Garitaonandia, I.
    Poustovoitov, M.
    Abramihina, T.
    McEntire, C. R.
    Culp, B.
    Attwood, J.
    Noskov, A.
    Semechkin, A.
    Laurent, L. C.
    Elsworth, J. D.
    Sladek, J.
    Snyder, E. Y.
    Redmond, D. E., Jr.
    Kern, R.
    CELL TRANSPLANTATION, 2016, 25 (04) : 758 - 759
  • [24] Opportunities and Challenges: Stem Cell-Based Therapy for the Treatment of Ischemic Stroke
    Tang, Yao-Hui
    Ma, Yuan-Yuan
    Zhang, Zhi-Jun
    Wang, Yong-Ting
    Yang, Guo-Yuan
    CNS NEUROSCIENCE & THERAPEUTICS, 2015, 21 (04) : 337 - 347
  • [25] Human Neural Stem Cell-Based Cell and Gene Therapy for Neurological Diseases
    Kim, S. U.
    CELL TRANSPLANTATION, 2012, 21 (04) : 784 - 784
  • [26] Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19
    Li, Chenghai
    Zhao, Hua
    Wang, Bin
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 3995 - 4001
  • [27] Challenges Facing Airway Epithelial Cell-Based Therapy for Cystic Fibrosis
    Berical, Andrew
    Lee, Rhianna E.
    Randell, Scott H.
    Hawkins, Finn
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [28] Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges
    Bagno, Luiza
    Hatzistergos, Konstantinos E.
    Balkan, Wayne
    Hare, Joshua M.
    MOLECULAR THERAPY, 2018, 26 (07) : 1610 - 1623
  • [29] Mesenchymal Stem Cell-Based Therapy for Stroke: Current Understanding and Challenges
    Li, Weifeng
    Shi, Linli
    Hu, Bei
    Hong, Yimei
    Zhang, Hao
    Li, Xin
    Zhang, Yuelin
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2021, 15
  • [30] Stem cell-based therapy and its potential in perioperative neurocognitive disorders
    Wei, Penghui
    Jia, Min
    Liu, Pan-miao
    Meng, Liying
    Li, Jianjun
    Yang, Jian-jun
    BRITISH JOURNAL OF ANAESTHESIA, 2023, 131 (04) : E139 - E142